Clinical Trial Update: Effect of Bydureon on Carotid Atherosclerosis Progression in Type 2 Diabetes Mellitus [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial is evaluating whether Bydureon (exenatide extended-release) affects progression of carotid atherosclerosis in adults with Type 2 diabet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Carotid Atherosclerosis
• Type 2 Diabetes Mellitus

Drugs mentioned

• Bydureon (exenatide)

Snippet

Sponsor: Phoenix VA Health Care System | Conditions: Type 2 Diabetes | Phase 4 | Status: UNKNOWN